Kai Yang

Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing Escherichia coli bacteremia: a retrospective study from 2013 to 2016

Yonghong Xiao, C. Ying, P. Shen, 2019, Antimicrobial Resistance & Infection Control.

Clinical prediction system of complications among patients with COVID-19: A development and validation retrospective multicentre study during first wave of the pandemic

Ghadeer O. Ghosheh, Farah E. Shamout, R. Ali, 2022, Intelligence-Based Medicine.

Socio-economic Burden of Bloodstream Infections Caused by Carbapenem-resistant and Carbapenem susceptible Pseudomonas aeruginosa in China.

Yonghong Xiao, Yanzi Zhou, Tingting Xiao, 2021, Journal of global antimicrobial resistance.

Social-Economic Burden of Patients with Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia Coli

Yonghong Xiao, P. Shen, Qixia Luo, 2020 .

Molecular Characteristics and Changing Trend of Methicillin-Resistant Staphylococcus Aureus From Invasive Infections between 2012 and 2018

Yonghong Xiao, Hao Xu, P. Shen, 2020 .

Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experience.

S. Jordan, A. Vo, M. Toyoda, 2006, Clinical journal of the American Society of Nephrology : CJASN.

Economic Burden of Patients with Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli

Yonghong Xiao, P. Shen, Qixia Luo, 2020, Infection and drug resistance.

Socioeconomic Burden of Bloodstream Infections Caused by Carbapenem-Resistant Enterobacteriaceae

Yonghong Xiao, P. Shen, Qixia Luo, 2020, Infection and drug resistance.

Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing Escherichia coli bacteremia: a retrospective study from 2013 to 2016

Yonghong Xiao, C. Ying, P. Shen, 2019, Antimicrobial Resistance & Infection Control.